Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease
-
- STATUS
- Not Recruiting
-
- participants needed
- 288
-
- sponsor
- Xuanwu Hospital, Beijing
Updated on 22 July 2024
Summary
Lingzhi(Ganoderma) is widely used in traditional Chinese medicine. Previous studies indicated that Lingzhi was safe, well tolorated, and improved symptoms as an add-on therapy to levodopa in early Parkinson's disease(PD) patients. Here the investigators design a multicenter, randomized, double-blind, placebo-controlled, delayed-start trial to evaluate the effects of Lingzhi on modifying disease progression in untreated PD patients.
Details
| Condition | Parkinson Disease |
|---|---|
| Age | 30years - 80years |
| Treatment | Placebos, Ganoderma |
| Clinical Study Identifier | NCT03594656 |
| Sponsor | Xuanwu Hospital, Beijing |
| Last Modified on | 22 July 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.